SGLT2 inhibitors look promising for glycaemic control

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1607, 2007-01, pp. : 16-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as well as Incretin-Related Drugs

Current Medicinal Chemistry, Vol. 23, Iss. 27, 2016-09 ,pp. : 3044-3051

Bentham Science Publishers

Access to resources Recommend Favorite

ACE inhibitors and ARBs look promising for diabetes prevention

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations

By Scheen André J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 5, 2014-05 ,pp. : 647-663

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments of C-Aryl Glucoside SGLT2 Inhibitors

Current Medicinal Chemistry, Vol. 23, Iss. 8, 2016-03 ,pp. : 832-849

Bentham Science Publishers

Access to resources Recommend Favorite

Phospholipase A2 inhibitors promising in CHD

Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite